Zimmer Biomet Holdings's total inventories for the quarter that ended in Mar. 2026 was €1,943 Mil. Zimmer Biomet Holdings's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was €1,948 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Zimmer Biomet Holdings's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was €-32.22.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Zimmer Biomet Holdings's Days Inventory for the
three
months ended in Mar. 2026 was 356.65.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zimmer Biomet Holdings's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.26.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zimmer Biomet Holdings's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.08.
Zimmer Biomet Holdings (FRA:ZIM) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Zimmer Biomet Holdings's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zimmer Biomet Holdings's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Zimmer Biomet Holdings Total Inventories Related Terms
Zimmer Biomet Holdings Total Inventories Historical Data
* Premium members only.
The historical data trend for Zimmer Biomet Holdings's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Zimmer Biomet Holdings (FRA:ZIM) has a Total Inventories of €1,943 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Zimmer Biomet Holdings and its competitors.
Is Zimmer Biomet Holdings' Total Inventories too high?
Zimmer Biomet Holdings' current Total Inventories is €1,943 Mil. Overall, Zimmer Biomet Holdings has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Total Inventories compare to PEN and GMED?
Zimmer Biomet Holdings' Total Inventories of €1,943 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Devices & Instruments company?
A good Total Inventories depends on the Medical Devices & Instruments industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Total Inventories is €1,943 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (FRA:ZIM) is currently considered Significantly Undervalued. The stock's GF Value™ is €109.16, compared to a current price of €76.80 — trading 29.6% below its estimated fair value. The current Total Inventories is €1,943 Mil. Zimmer Biomet Holdings' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Zimmer Biomet Holdings (FRA:ZIM), the current Total Inventories is €1,943 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (FRA:ZIM) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of €76.80 is trading 29.6% below its estimated GF Value™ of €109.16.
GuruFocus considers Zimmer Biomet Holdings to be Significantly Undervalued.
Key valuation signals for FRA:ZIM:
Total Inventories: €1,943 Mil
GF Value™: €109.16 vs. price of €76.80 (29.6% below fair value)
No single metric tells the full story. See the FRA:ZIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
76GF Score
Get the complete analysis for FRA:ZIM
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ZIM has been successfully added to your 
